Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · 2005
In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wild Damian, Eyrich Gerold K, Ciernik Ilja F, Stoeckli Sandro J, Schuknecht Bernhard, Goerres Gerhard W
Аннотация
BACKGROUND: Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are the standard imaging techniques to evaluate patients with carcinoma in the sinus/nasal area and orbit. The use of positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) in such patients is as yet less well established.
PURPOSE: The aim of this study was to assess the clinical impact of PET co-registered with CT (PET/CT).
PATIENTS: Evaluation of 21 consecutive patients.
METHODS: A retrospective analysis of the whole body PET/CT studies was done. Images were assessed visually without knowing the results of the other imaging technique. Histology and clinical follow-up served to verify lesions. The clinical impact on therapy was assessed together with the physician in charge.
RESULTS: All patients underwent PET/CT and CT or MRI for staging (n=9 scans) and restaging (n=17 scans) without treatment between the examinations. PET/CT changed the treatment protocol in 2 patients at staging and in 7 at re-staging. Distant metastases were found in 5 and a secondary tumour in 1 patient.
CONCLUSIONS: Whole body PET/CT adds clinically important information to CT or MRI, thus, influencing treatment.
PURPOSE: The aim of this study was to assess the clinical impact of PET co-registered with CT (PET/CT).
PATIENTS: Evaluation of 21 consecutive patients.
METHODS: A retrospective analysis of the whole body PET/CT studies was done. Images were assessed visually without knowing the results of the other imaging technique. Histology and clinical follow-up served to verify lesions. The clinical impact on therapy was assessed together with the physician in charge.
RESULTS: All patients underwent PET/CT and CT or MRI for staging (n=9 scans) and restaging (n=17 scans) without treatment between the examinations. PET/CT changed the treatment protocol in 2 patients at staging and in 7 at re-staging. Distant metastases were found in 5 and a secondary tumour in 1 patient.
CONCLUSIONS: Whole body PET/CT adds clinically important information to CT or MRI, thus, influencing treatment.
Предметные рубрики MeSH
AdolescentAdultAgedAged, 80 and overCarcinomaFemaleFluorodeoxyglucose F18Follow-Up StudiesHumansImage Processing, Computer-AssistedMaleMiddle AgedNeoplasm MetastasisNeoplasm Recurrence, LocalNeoplasm StagingNeoplasm, ResidualNeoplasms, Second PrimaryNose NeoplasmsOrbital NeoplasmsParanasal Sinus NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesTomography, Spiral ComputedWhole Body Imaging